A five-year survival rate of approximately 10% to 90% can be achieved with treatment of moderately differentiated carcinoma of the rectum and needs to be analyzed on a case-by-case basis. The eradication rate is generally not used to represent the specific prognosis.
Rectal cancer is a malignant tumor of the intestinal tract caused by poor dietary habits, genetic mutations and other factors. Moderately differentiated is the degree of differentiation of tumor cells, indicating average malignancy and average prognosis. Usually rectal cancer is mainly treated by surgical resection, radiotherapy and targeted therapy after diagnosis.
After active treatment, the five-year survival rate of patients should be judged in combination with clinical staging. Stage I is about 90%; Stage II-III is about 40%-70%; Stage IV can be only 10%. In short, the later the stage, the worse the prognosis, so we should strive for early detection, diagnosis, treatment, specific can consult a professional physician’s opinion.